| RE49517 |
Pyrazoles |
Rudolf Schindler, Hans-Joachim Lankau, Norbert Höfgen, Christian Grunwald, Ute Egerland +3 more |
2023-05-02 |
| 10323021 |
Triazoles as NR2B receptor inhibitors |
Rudolf Schindler, Hans-Joachim Lankau, Norbert Höfgen, Ute Egerland, Rita Dost +1 more |
2019-06-18 |
| 10155727 |
Pyrazoles |
Rudolf Schindler, Hans-Joachim Lankau, Norbert Höfgen, Christian Grunwald, Ute Egerland +3 more |
2018-12-18 |
| 9981950 |
Triazoles as NR2B receptor inhibitors |
Rudolf Schindler, Hans-Joachim Lankau, Norbert Höfgen, Ute Egerland, Rita Dost +1 more |
2018-05-29 |
| 9540379 |
(1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases |
Hans-Joachim Lankau, Christian Grunwald, Norbert Hoefgen, Hans Stange, Rita Dost +1 more |
2017-01-10 |
| 9085584 |
Substituted pyrido[3,2-E][1,2,4]-triazolo[4,3-A]pyrazines for the treatment of central nervous system disorders |
Riccardo Giovannini, Barbara Bertani, Sara Frattini, Giustino DI ANTONIO, Hans-Joachim Lankau +4 more |
2015-07-21 |
| 7875618 |
Substituted imidazo[1,5-a]quinoxalines useful as inhibitors of phosphodiesterase 10 for the treatment of neurological and other disorders |
Michael S. Malamas, Yike Ni, James Joseph Erdei, Norbert Höfgen, Hans Stange +2 more |
2011-01-25 |
| 7550465 |
Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them |
Norbert Höfgen, Hans Stange, Ute Egerland, Rudolf Schindler, Thomas Pfeifer +1 more |
2009-06-23 |
